<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="366634">
  <stage>Registered</stage>
  <submitdate>1/07/2014</submitdate>
  <approvaldate>8/07/2014</approvaldate>
  <actrnumber>ACTRN12614000724673</actrnumber>
  <trial_identification>
    <studytitle>Effect of renal specific vitamins and minerals supplementation (KVITAL) on the nutritional status and psychological wellbeing of the Haemodialysis patient: pilot study</studytitle>
    <scientifictitle>  Effect of renal specific vitamins and minerals supplementation (KVITAL) on the nutritional status and psychological wellbeing of the Haemodialysis patient: pilot study</scientifictitle>
    <utrn>U1111-1158-6998</utrn>
    <trialacronym />
    <secondaryid>NIL</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Chronic Kidney Disease </healthcondition>
    <conditioncode>
      <conditioncode1>Renal and Urogenital</conditioncode1>
      <conditioncode2>Kidney disease</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Assess whether routine vitamins supplementation, using a brand of vitamins formulation that is appropriate for Chronic Kidney Disease (Kidney Vital) improves patients nutritional status and quality of life.  One tablet to be taken daily, orally for 6 months
Active Ingredients and doses outlined below.
Ascorbic acid 60 mg
Biotin 30 microgram
Calcium pantothenate 5 mg
Cholecalciferol .025 mg
Copper gluconate 900 microgram
Cyanocobalamin 2.4 microgram
Ferrous fumarate 8 mg
Folic acid 400 microgram
Nicotinic acid 20 mg
Pyridoxine hydrochloride 10 mg
Riboflavin 2 mg
Sodium selenate 55 microgram
Thiamine nitrate 1.5 mg
Zinc oxide
 Vitamin levels will be monitored with pathology testing,  pre study and post commencement of study. Patients will be given a SF-36 Quality of life questionnaire and Subjective Global Assessment pre and post commencment of study to enstablish patient nutritional and psychological wellbeing.
Patients will be educated on the benefits of taking a daily vitamin supplement to their nutritional status and well being.</interventions>
    <comparator>No control group</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Treatment: Drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Vitamin and mineral defiency in haemodialysis patients may be improved with vitamin supplementation.
This outcome will be assessed by comparing pre study and post study blood pathology of vitamin and mineral levels </outcome>
      <timepoint>At 6 months post commencement of vitamin supplement </timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Patients nutritional status and quality of life may be improved with implementation of a renal specific vitamin supplement to the haemodialysis patient.
This outcome will be assessed using SGA and SF-36 Quality of life questionnaire, comparing pre and post results  of vitamin supplement</outcome>
      <timepoint>6 months post commencement of vitamin supplement</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Nil</outcome>
      <timepoint>Nil</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Chronic Kidney Disease stage 5 currently on haemodialysis at selected satellite unit</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>90</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Unable to comply to taking vitamin tablet daily for six month period of study</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment>Patients will be educated on the benefits of taking a daily vitamin supplement.  They will be advised they will be required to purchase the supplement and commit to taking the vitamin for the 6 months of the trial poject.</concealment>
    <sequence />
    <masking>Open (masking not used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 1</phase>
    <anticipatedstartdate>1/08/2014</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate>19/08/2014</anticipatedenddate>
    <actualenddate />
    <samplesize>42</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC</recruitmentstate>
    <hospital>Frankston Hospital - Frankston</hospital>
    <postcode>3199 - Frankston</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Frankston Hospital Department of Medicine- Renal</primarysponsorname>
    <primarysponsoraddress>Frankston Hospital 
2 Hastings Rd 
Frankston, Victoria, 3199</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Frankston Hospital Department of Medicine - Renal </fundingname>
      <fundingaddress>2 Hastings Rd
Frankston, Victoria, 3199</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Assess whether routine vitamins supplementation, that is appropriate for Chronic Kidney Disease (Kidney Vital) improves patients nutritional status and quality of life.  </summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Research and Ethics</ethicname>
      <ethicaddress>Peninsula Health
PO Box  192 
 Mount Eliza VIC  3930</ethicaddress>
      <ethicapprovaldate>25/06/2014</ethicapprovaldate>
      <hrec>13/PH/45</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Kim Wong</name>
      <address>Nephrologist
Frankston Hospital 
Department of Medicine- Renal 
2 Hastings Rd, 
Frankston, Victoria, 3199</address>
      <phone>+ 61 3 9784 7777</phone>
      <fax>+61 3 9784 7289</fax>
      <email>kwong@phcn.vic.gov.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Mrs</title>
      <name>Julie Chimyong</name>
      <address>Nephrology Nurse Practitioner 
Frankston Hospital 
Haemodialysis Unit
2 Hastings Rd
Frankston, Victoria, 3199</address>
      <phone>+61 3  9784 8287</phone>
      <fax>+ 61 3 9784 7289</fax>
      <email>jchimyong@phcn.vic.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Ms</title>
      <name>Lee-Anne Clavarino</name>
      <address>Peninsula Health
PO Box  192 Mount Eliza VIC  3930</address>
      <phone>+61 3 9788 1473 </phone>
      <fax />
      <email>lclavarino@phcn.vic.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Mrs</title>
      <name>Julie Chimyong</name>
      <address>Nephrology Nurse Practitioner 
Frankston Hospital 
Haemodialysis Unit
2 Hastings Rd
Frankston, Victoria, 3199</address>
      <phone>+61 3 9784 8287</phone>
      <fax>+61 3 9784 7289</fax>
      <email>jchimyong@phcn.vic.gov.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>